Literature DB >> 13257940

The use of myleran in the treatment of chronic myelocytic leukemia.

A HAUT, S J ALTMAN, G E CARTWRIGHT, M M WINTROBE.   

Abstract

Entities:  

Keywords:  GLYCOLS/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy

Mesh：

Substances：

Year:  1955        PMID： 13257940     DOI： 10.1001/archinte.1955.00250150025002

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  4 in total

1.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

2.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

3.  Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Authors:  F G HAYHOE; D KOK
Journal:  Br Med J       Date:  1957-12-21

4.  Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.

Authors:  Kaylind Batey; Jisoo Kim; Lauren Brinster; Gladys Gonzalez-Matias; Zhijie Wu; Sabrina Solorzano; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2021-11-08       Impact factor: 3.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.